Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP1 | P11387 | 7/20 | 0.54 |
| ▸ | ATR | Q13535 | 1/20 | 0.43 |
| ▸ | MET | P08581 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 3/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.40 |
| ▸ | KDR | P35968 | 1/20 | 0.40 |
| ▸ | FLT3 | P36888 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.38 |
| ▸ | BCHE | P06276 | 1/20 | 0.38 |
| ▸ | TNF | P01375 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23946379 | 0.91 | TOP1 (0.60) | TOP1METNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL23946299 | 0.87 | TOP1 (0.49) | TOP1ATRMETNPC1RAB9A | |
| SCHEMBL27775278 | 0.84 | NPC1 (0.53) | TOP1ATRNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL11987282 | 0.78 | ATR (0.47) | TOP1ATRNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL9885994 | 0.77 | MET (0.54) | TOP1METNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL24905367 | 0.74 | TOP1 (0.40) | TOP1METNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL2517043 | 0.74 | GAA (0.52) | TOP1METNPC1RAB9AMAPK1 | |
| SCHEMBL29645242 | 0.74 | GAA (0.52) | TOP1METNPC1RAB9AMAPK1 | |
| Biphenyl SCHEMBL27643410 | 0.73 | HSD17B10 (0.44) | TOP1METNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL16750251 | 0.73 | ATR (0.54) | ATRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210328153-A1 | ELECTROLUMINESCENT MATERIALS AND DEVICES | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2021-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210328153-A1 | ELECTROLUMINESCENT MATERIALS AND DEVICES | IDO1, IDO2, AZI2 | TOP1 2508/4885ATR 3057/4885MET 4563/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.